Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 57:1158-1159, 2008
DOI: 10.2337/db08-0315
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cherrington, A. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cherrington, A. D.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Commentary

Central Versus Peripheral Glucose Sensing and the Response to Hypoglycemia

Alan D. Cherrington

From the Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee

Corresponding author: Vanderbilt University Medical School, Department of Molecular Physiology and Biophysics, 704 Robinson Research Building, Nashville, TN 37232-0615. E-mail: alan.cherrington@vanderbilt.edu

The first 20% of the full text of this article appears below.

One of the most significant limits in our ability to tightly control blood glucose in patients with diabetes is the occurrence of hypoglycemia. It is now clear that when blood glucose drops in a normal individual, there is a rapid and well-coordinated endocrine response (1). Glucagon, epinephrine, norepinephrine, cortisol, and growth hormone levels rise as the glucose level falls (1). The combination of low blood glucose and elevated hormones limits glucose utilization by the tissues of the body and stimulates glucose production by the liver (2). As a consequence of these metabolic adjustments, the fall in blood glucose is limited and the ensuing hypoglycemia is minimized. In an individual with diabetes, the glucagon response to hypoglycemia begins to diminish relatively early in the disease process (1). Later, even the sympatho-adrenal response may become limited (1). As a consequence, individuals with diabetes, particularly type 1 diabetes, are at increased risk for serious hypoglycemia. Understanding more about the normal response to hypoglycemia and about the failure of the normal response in diabetic individuals is thus of great importance.

A recent debate in this area relates to the site of hypoglycemic sensing. While it has long been known that the brain is involved in detecting low blood glucose, data began to appear in the early 1990s supporting the view that hypoglycemic sensing was also occurring at peripheral sites, particularly within the hepato-portal region. A series of articles . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article:

The Locus for Hypoglycemic Detection Shifts With the Rate of Fall in Glycemia: The Role of Portal–Superior Mesenteric Vein Glucose Sensing
Maziyar Saberi, MaryAnn Bohland, and Casey M. Donovan
Diabetes 2008 57: 1380-1386. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.